Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4429063 | 1.00 | CES2 (0.43) | CES2GBA1THRBMEN1HTT | |
| SCHEMBL4429558 | 1.00 | CES2 (0.43) | CES2GBA1THRBMEN1HTT | |
| SCHEMBL4425605 | 1.00 | CES2 (0.43) | CES2GBA1THRBMEN1HTT | |
| SCHEMBL14939281 | 1.00 | CES2 (0.43) | CES2GBA1THRBMEN1HTT | |
| SCHEMBL4432502 | 1.00 | CES2 (0.43) | CES2GBA1THRBMEN1HTT | |
| SCHEMBL4437405 | 1.00 | CES2 (0.43) | CES2GBA1THRBMEN1HTT | |
| SCHEMBL5077032 | 1.00 | CES2 (0.43) | CES2GBA1THRBMEN1HTT | |
| SCHEMBL4430804 | 0.98 | CES2 (0.40) | CES2GBA1THRBMEN1HTT | |
| SCHEMBL4429201 | 0.90 | — | — | |
| SCHEMBL4371579 | 0.90 | CES2 (0.30) | CES2GBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2776545-B1 | CANDLE WAX COMPRISING A POLYMER AND METHOD FOR MAKING CANDLE WAX | Nchem BVBA (BE) | 2017-10-11 | — | — | EP | disclosed |
| US-9580669-B2 | Candle wax comprising a polymer and method for making candle wax | Nchem BVBA (BE) | 2017-02-28 | — | — | US | disclosed |
| US-20140290126-A1 | CANDLE WAX COMPRISING A POLYMER AND METHOD FOR MAKING CANDLE WAX | Nchem BVBA (BE) | 2014-10-02 | — | — | US | disclosed |
| EP-2776545-A1 | CANDLE WAX COMPRISING A POLYMER AND METHOD FOR MAKING CANDLE WAX | N-Chemie Comm. V. (BE) | 2014-09-17 | — | — | EP | disclosed |
| WO-2013068385-A1 | CANDLE WAX COMPRISING A POLYMER AND METHOD FOR MAKING CANDLE WAX | N-CHEMIE COMM. V. (BE) | 2013-05-16 | — | — | WO | disclosed |
| US-7544461-B2 | Near infrared ray activation type positive resin composition | KANSAI PAINT CO., LTD. (JP) | 2009-06-09 | — | — | US | disclosed |
| US-7358030-B2 | Process for producing ether compound | KYOWA YUKA CO., LTD. (JP) | 2008-04-15 | — | — | US | disclosed |
| US-20070259279-A1 | Near Infrared Ray Activation Type Positive Resin Composition | KANSAI PAINT CO., LTD. (JP) | 2007-11-08 | — | — | US | disclosed |
| EP-1788432-A1 | POSITIVE RESIN COMPOSITION OF NEAR-INFRARED-RAY ACTIVATION TYPE | Kansai Paint Co., Ltd. (JP) | 2007-05-23 | — | — | EP | disclosed |
| US-20060074262-A1 | Process for producing ether compound | KYOWA YUKA CO., LTD. (JP) | 2006-04-06 | — | — | US | disclosed |
| US-7015363-B2 | Process for producing ether compound | KYOWA YUKA CO., LTD. (JP) | 2006-03-21 | — | — | US | disclosed |
| US-20040181097-A1 | Process for producing ether compound | KYOWA YUKA CO., LTD. (JP) | 2004-09-16 | — | — | US | disclosed |
| EP-1415968-A1 | PROCESS FOR PRODUCING ETHER COMPOUND | Kyowa Yuka Co., Ltd. (JP) | 2004-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074262-A1 | Process for producing ether compound | AGL, ARL1, CYP2C8 | CES2 61/4885GBA1 2558/4885THRB 3363/4885 |
| US-20040181097-A1 | Process for producing ether compound | CYP2E1, ARL1, MRPL21 | CES2 95/4885GBA1 2671/4885THRB 3460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.